Abstract:Identifying disease-resistant and disease-susceptible materials in largemouth bass can provide fundamental analytical information for disease-resistant breeding research on this species. To date, no stable and effective artificial infection pathway has been established against largemouth bass virus (LMBV) in largemouth bass. In this study, using the pathogen at a concentration of 1.60 x 105 TCID50/mL, largemouth bass juveniles were infected using three different methods: muscle injection, feeding, and immersion. A comprehensive comparative study was conducted on parameters such as disease progression, viral load, pathological changes, and electron microscopy. The results revealed that the injection group experienced rapid mortality, with all individuals dying within 6 days after the infection. The feeding group showed minimal mortality, with an overall mortality rate of 28.57%. The immersion group reached its peak mortality on the 9th day after infection, with an accumulated mortality rate of 63.24%. Viral gene quantification results showed that while in the injection group muscles had the highest viral load followed by the liver and spleen, the other infection methods led to the highest viral loads in the liver and spleen. Tissue pathology and electron microscopy observations revealed that the liver and spleen exhibited the most significant pathological changes and were the easiest organs to detect viral particles, indicating that the liver and spleen are the primary target organs of LMBV in largemouth bass. In conclusion, this study suggests that immersing largemouth bass in LMBV at a concentration of 1.99 x 103 c/mL (diluted 80 times) closely mimics the natural infection rate, allowing for a clear differentiation between causes of death and survival, making it an almost non-invasive artificial infection method that closely resembles natural infection conditions. These findings can provide crucial support for the accurate identification of disease-resistant and disease-susceptible materials in largemouth bass and the breeding of disease-resistant varieties.

Evaluation of Epitope Vaccine Based on Phage Display Technology for Largemouth Bass Virus

Production and evaluation of three kinds of vaccines against Largemouth bass virus, and DNA vaccines show great application prospects

Oral Vaccination of Largemouth Bass (Micropterus salmoides) against Largemouth Bass Ranavirus (LMBV) Using Yeast Surface Display Technology

Oral Vaccination With Recombinant Pichia pastoris Expressing Iridovirus Major Capsid Protein Elicits Protective Immunity in Largemouth Bass (Micropterus salmoides)

Immunoprotective effect of recombinant Lactobacillus plantarum expressing largemouth bass virus MCP on largemouth bass

A naturaly attenuated largemouth bass ranavirus strain provided protection for Micropterus salmoides by immersion immunization

Isolation, identification, and monoclonal antibody development of largemouth bass virus

Antigenic epitope screening and functional modification of mannose enhance the efficacy of largemouth bass virus subunit vaccines

Surface Display of Major Capsid Protein on Bacillus Subtilis Spores Against Largemouth Bass Virus (LMBV) for Oral Administration

An Avirulent Largemouth Bass Birnavirus Vaccine Candidate Protects Largemouth Bass against Birnavirus Infection

The Immunoadjuvant Effects of Interleukin-8 on Aeromonas Veronii Inactivated Vaccine in Largemouth Bass (micropterus Salmoides)

Protective efficacy and immune responses of largemouth bass (Micropterus salmoides) immunized with an inactivated vaccine against the viral hemorrhagic septicemia virus genotype IVa

Lactobacillus casei displaying MCP2α and FlaC delivered by PLA microspheres effectively enhances the immune protection of largemouth bass (Micropterus salmoides) against LMBV infection

Oral administration of recombinant Lactococcus lactis expressing largemouth bass (Micropterus salmoides) IFNa3 protein enhances immune response against largemouth bass virus (LMBV) infection

Selection and Characterization of ssDNA Aptamers Targeting Largemouth Bass Virus Infected Cells With Antiviral Activities

Oral Recombinant Pichia Pastorisp-I20h Combined with Immunopotentiator Curcumin Remarkably Inhibits and Clears Lmbv in Largemouth Bass (micropterus Salmoides )

Protective Immunity by DNA Vaccine Against Micropterus Salmoides Rhabdovirus.

Artificial Infection Pathway of Largemouth Bass LMBV and Identification of Resistant and Susceptible Individuals

A nanobody-mediated drug system against largemouth bass virus delivered by bacterial nanocellulose in Micropterus salmoides

Comparison and Evaluation of DNA Vaccines Against Nocardia Seriolae Infection in Largemouth Bass (micropterus Salmoides)

The oral antigen-adjuvant fusion vaccine P-MCP-FlaC provides effective protective effect against largemouth bass ranavirus infection